Brief: Pacbio Announces Fourth Quarter And Fiscal Year 2022 Financial Results
16/02/2023 23:01
Feb 16 (Reuters) - Pacific Biosciences Of California Inc
PACB.O :
* PACBIO ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2022
FINANCIAL
RESULTS
* Q4 REVENUE FELL 24 PERCENT TO $27.4 MILLION
* NET LOSS PER SHARE FOR Q4 OF 2022 WAS $0.37
* NON-GAAP NET LOSS PER SHARE FOR Q4 OF 2022 WAS $0.35
* Q4 EARNINGS PER SHARE VIEW $-0.36, REVENUE VIEW $26.2
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nPn2NKx3ja
Further company coverage: PACB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacific Biosciences of California
See all newsBrief: Pacbio And Verily Health Announce Multi-Year Strategic Collaboration
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary
Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure
Brief: Pacific Biosciences of California Q2 EPS USD -0.14
Pacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview